Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, provides the following update on trading for the year ended 30 April 2019 ahead of announcing its full-year results in early July 2019.
As noted in the interim results announcement, Kromek entered the second half of 2018/19 in a stronger position than at the same point of the prior year with the Company delivering on its previously-signed customer product contracts in all of its segments as well as continuing to win new orders. This progress continued throughout the period and, as a result, the Company expects to report revenue growth for the full year 2018/19 and EBITDA profit in-line with market expectations.
The Company continues to gain traction in all its business segments with the award of high-value, multi-year contracts from its commercial and large government customers worldwide. With the increasing market adoption of its customers’ next-generation products that incorporate Kromek’s radiation detection solutions, combined with the successful fundraising completed in the second half of 2018/19, the Company is well-placed to capitalise on the expanding opportunities. Consequently, the Board continues to look to the future with confidence.